The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study-Reference-Cited by-同舟云学术

The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study

Published:2019-03 Issue:1 Volume:2 Page:16-21
ISSN:2096-5664
Container-title:Journal of Pancreatology
language:en
Short-container-title:

Author:

Wu Wenming,Jin Gang,Wang Chunyou,Miao Yi,Wang Huaizhi,Lou Wenhui,Yu Xianjun,Sun Bei,Li Haimin,Qin Renyi,Wu Zheng,Wang Weilin,Xu Kesen,Wang Lei,Liang Tingbo,Hao Chunyi,Huang Heguang,Li Yixiong,Tan Guang,Zhao Yongfu,Hao Jihui,Wang Yifan,Peng Chenghong,Liu Xubao,Ou Jinrui,Yuan Chunhui,Wang Xuefeng,Yang Yinmo,Cai Shouwang,Guo Kejian,Jiang Jianxin,Yu Xiao,Wei Junmin,Li Fei,Wu Xinmin,Zhao Yupei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference28 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Chemotherapy and tumor microenvironment of pancreatic cancer;Liu;Cancer Cell Int,2017

3. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

4. Diabetes, plasma glucose and incidence of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million people;Pang;Hepatology,2018

5. Risk factors for pancreatic cancer in china: a multicenter case–control study;Zheng;J Epidemiol,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma;Cellular Oncology;2023-06-01

2. mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine models;Cancer Letters;2023-02

3. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases;Frontiers in Oncology;2023-01-09

4. Identification of HnRNP Family as Prognostic Biomarkers in Five Major Types of Gastrointestinal Cancer;Current Gene Therapy;2022-10

5. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma;Pancreatology;2022-09